NORDEA INVESTMENT MANAGEMENT AB

Position in ZTS — Zoetis Inc.

CIK 1218210 STOCKHOLM, V7

Back to ZTS Full portfolio

Position in ZTS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$693,314,769

+$72,671,510 QoQ

Shares Held

5,865,111

+18.9% QoQ

Ownership

1.40%

of shares outstanding

% of Portfolio

0.65%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 1.1487932623952044.ToString("F0")% Shared 0.ToString("F0")% None 98.8512067376048.ToString("F0")%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

NORDEA INVESTMENT MANAGEMENT AB holds $757,413,866 across 8 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (91.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc. This page	5,865,111	$693,314,769
2	PBH	Prestige Consumer Healthcare Inc.	599,375	$35,524,955
3	UTHR	UNITED THERAPEUTICS Corp	14,255	$8,452,929
4	NBIX	Neurocrine Biosciences Inc	43,136	$5,682,735
5	KNSA	Kiniksa Pharmaceuticals International, plc	106,635	$5,134,474
6	TEVA	Teva Pharmaceutical Industries Ltd	124,860	$3,760,783
7	LNTH	Lantheus Holdings, Inc.	41,101	$3,117,510
8	AMPH	Amphastar Pharmaceuticals, Inc.	123,824	$2,425,711

All Filings in ZTS

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$693,314,769	5,865,111	+18.9%	Shares	Defined	2026-05-13
2025-12-31	$620,643,259	4,932,787	+79.2%	Shares	Defined	2026-01-08
2025-09-30	$402,849,539	2,753,209	+16.9%	Shares	Defined	2025-10-27
2025-06-30	$367,444,087	2,356,166	+10.0%	Shares	Defined	2025-07-29
2025-03-31	$352,561,256	2,141,277	+3.7%	Shares	Defined	2025-05-14
2024-12-31	$336,534,194	2,065,514	+38.3%	Shares	Sole	2025-01-06
2024-09-30	$291,702,925	1,493,003	+11.1%	Shares	Sole	2024-11-05
2024-06-30	$232,989,945	1,343,966	+7.5%	Shares	Sole	2024-08-08
2024-03-31	$211,613,179	1,250,595	+3.2%	Shares	Sole	2024-05-02
2023-12-31	$239,281,519	1,212,350	-1.8%	Shares	Sole	2024-01-10
2023-09-30	$214,691,146	1,233,999	+13.7%	Shares	Sole	2023-11-13
2023-06-30	$186,830,284	1,084,898	+5.5%	Shares	Sole	2023-07-07
2023-03-31	$171,228,645	1,028,771	+0.6%	Shares	Sole	2023-04-19
2022-12-31	$149,812,789	1,022,264	+1.3%	Shares	Sole	2023-02-08
2022-09-30	$149,633,062	1,009,057	-5.5%	Shares	Sole	2022-10-19
2022-06-30	$183,600,693	1,068,129	-2.6%	Shares	Sole	2022-08-09
2022-03-31	$206,883,418	1,097,001	+2.4%	Shares	Sole	2022-04-11
2021-12-31	$261,418,357	1,071,255	+2.0%	Shares	Sole	2022-01-20
2021-09-30	$203,994,934	1,050,762	+2.0%	Shares	Sole	2021-11-01
2021-06-30	$191,960,677	1,030,053	+12.8%	Shares	Sole	2021-07-16
2021-03-31	$143,851,680	913,460	+5.4%	Shares	Sole	2021-05-17
2020-12-31	$143,470,295	866,890	+10.0%	Shares	Sole	2021-02-12
2020-09-30	$130,272,201	787,762	-43.9%	Shares	Sole	2020-11-09
2020-06-30	$192,542,296	1,405,008	+103.0%	Shares	Sole	2020-08-13
2020-03-31	$81,462,428	692,178	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.